Aptevo Therapeutics Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Aptevo Therapeutics Inc. (APVO) reported Cost of Goods Sold (Deprecated 2018-01-31) of $5.01 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-03-13
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.90M, a 62.68% decline year-over-year.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.87M, a 54.45% decline year-over-year.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $5.90M, a 9.89% decline year-over-year.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $488.00K, a 86.17% decline year-over-year.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $5.01M, a 59.81% decline from fiscal 2016.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $12.47M, a 26.37% decline from fiscal 2015.
- Aptevo Therapeutics Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $16.93M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $3.77M derived: sum of 2 quarters · filed 2018-03-13 | $9.66M derived: sum of 3 quarters · filed 2018-03-13 | $5.01M 10-K · filed 2018-03-13 | |||
| 2017-09-30 | $1.87M 10-Q · filed 2017-11-13 | $7.77M derived: sum of 2 quarters · filed 2017-11-13 | $3.11M 10-Q · filed 2017-11-13 | $13.34M derived: sum of 4 quarters · filed 2018-03-13 | |||
| 2017-06-30 | $5.90M 10-Q · filed 2017-08-10 | $6.38M 10-Q · filed 2017-08-10 | $11.46M derived: sum of 3 quarters · filed 2018-03-13 | $15.57M derived: sum of 4 quarters · filed 2018-03-13 | |||
| 2017-03-31 | $488.00K 10-Q · filed 2017-05-12 | $5.57M derived: sum of 2 quarters · filed 2018-03-13 | $9.68M derived: sum of 3 quarters · filed 2018-03-13 | $16.22M derived: sum of 4 quarters · filed 2018-03-13 | |||
| 2016-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $9.19M derived: sum of 2 quarters · filed 2018-03-13 | $15.73M derived: sum of 3 quarters · filed 2018-03-13 | $12.47M 10-K · filed 2018-03-13 | $24.18M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $4.11M 10-Q · filed 2017-11-13 | $6.16M 10-Q · filed 2016-11-14 | $10.65M derived: sum of 2 quarters · filed 2017-11-13 | $7.39M 10-Q · filed 2017-11-13 | $16.23M 10-Q · filed 2016-11-14 | $19.42M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $6.54M 10-Q · filed 2017-08-10 | $10.07M 10-Q · filed 2017-08-10 | $15.31M derived: sum of 3 quarters · filed 2017-08-10 | $18.83M derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $3.53M 10-Q · filed 2017-05-12 | $8.77M derived: sum of 2 quarters · filed 2017-05-12 | $12.29M derived: sum of 3 quarters · filed 2017-05-12 | $16.73M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $8.76M derived: sum of 2 quarters · filed 2017-03-31 | $13.20M derived: sum of 3 quarters · filed 2017-03-31 | $16.93M 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $3.52M 10-Q · filed 2016-11-14 | $7.96M derived: sum of 2 quarters · filed 2016-11-14 | $11.70M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $4.44M 10-Q/A · filed 2016-09-22 | $8.17M 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |